WHO cheers COVID-19 trial results of dexamethasone
World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus Tuesday called initial clinical trial results of a steroid shown to reduce deaths in critically ill coronavirus patients “great news.”
“This is the first treatment to be shown to reduce mortality in patients with COVID-19 requiring oxygen or ventilator support,” Ghebreyesus said of dexamethasone, which reduced the mortality of those on ventilators in the trial by one-third.
“This is great news and I congratulate the Government of the UK, the University of Oxford, and the many hospitals and patients in the UK who have contributed to this lifesaving scientific breakthrough,” he said in a statement.
Currently, 50 percent of COVID-19 patients who need a ventilator don’t survive, according to BBC News.
Dexamethasone, which has been used since the 1960s as an anti-inflammatory for arthritis and asthma patients, is inexpensive and widely available.
University of …continued .
[Source: Fox News]